Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 304

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia

Open access
Salen, G., von Bergmann, K., Lütjohann, D., Kwiterovich, P., Kane, J., Patel, S.B., Musliner, T., Stein, P., Musser, B., the Multicenter Sitosterolemia Study Group·2004·Circulation

Abstract

Background— Sitosterolemia is a recessively inherited disorder that results from mutations in either ABCG5 or G8 proteins, with hyperabsorption of dietary sterols and decreased hepatic excretion of plant sterols and cholesterol. As a consequence of markedly elevated plasma and tissue sitosterol and campesterol levels, premature atherosclerosis develops. Methods and Results— In this multicenter, double-blind, randomized, placebo-controlled study, we examined whether treatment with ezetimibe, an inhibitor of cholesterol absorption, reduces plant sterol levels in patients with sitosterolemia. After a 3-week placebo run-in, 37 patients were randomized to receive placebo (n=7) or ezetimibe 10 mg/d (n=30) for 8 weeks. Sitosterol concentrations decreased by 21% ( P <0.001) in patients treated with ezetimibe compared with a nonsignificant 4% rise in those on placebo (between-group P <0.001). The reduction in sitosterol from baseline was progressive, with further decline observed at each subsequent biweekly visit. Campesterol also progressively declined, with a mean decrease after 8 weeks of 24% with ezetimibe and a mean increase of 3% with placebo treatment (between-group P <0.001). Reductions in plant sterol concentrations were similar irrespective of whether patients were undergoing concomitant treatment with resin or statin. Reductions in total sterols and apolipoprotein B were also observed. Ezetimibe was well tolerated, with no serious treatment-related adverse events or discontinuations due to adverse events being reported. Conclusions— Ezetimibe produced significant and progressive reductions in plasma plant sterol concentrations in patients with sitosterolemia, consistent with the hypothesis that ezetimibe inhibits the intestinal absorption of plant sterols as well as cholesterol, leading to reductions in plasma concentrations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000116766.31036.03

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 304

Metadata

Authors
Salen, G., von Bergmann, K., Lütjohann, D., Kwiterovich, P., Kane, J., Patel, S. B., Musliner, T., Stein, P., Musser, B., & the Multicenter Sitosterolemia Study Group
Venue
Circulation
Published
2004-03-02
Volume
109
Issue
8
Pages
966-971
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2066342412
Cited by
304
References
1
FWCI
26.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia. https://app.cochat.ai/papers/10.1161/01.cir.0000116766.31036.03
The paper
Salen, G., von Bergmann, K., Lütjohann, D., Kwiterovich, P., Kane, J., Patel, S. B., Musliner, T., Stein, P., Musser, B., & the Multicenter Sitosterolemia Study Group. (2004). Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia. Circulation. https://doi.org/10.1161/01.cir.0000116766.31036.03

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.